Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00383
|
|||||
| Drug Name |
Dolutegravir
|
|||||
| Synonyms |
DTG; S/GSK1349572
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Human immunodeficiency virus infection [ICD11: 1C62.Z] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H19F2N3O5
|
|||||
| Canonical SMILES |
CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
|
|||||
| InChI |
InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1
|
|||||
| InChIKey |
RHWKPHLQXYSBKR-BMIGLBTASA-N
|
|||||
| CAS Number |
CAS 1051375-16-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 419.4 | Topological Polar Surface Area | 99.2 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
2.4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
123055423
, 124361075
, 124361082
, 124361088
, 135268073
, 135273443
, 135626786
, 136340316
, 136349541
, 136367672
, 136920429
, 144115916
, 152258477
, 160647312
, 160693271
, 162011364
, 162038052
, 162202774
, 163677014
, 164043525
, 164193963
, 164347381
, 170484068
, 170484069
, 170484070
, 170503405
, 174007466
, 174525979
, 175427161
, 178103937
, 184812380
, 189622844
, 198935766
, 198993556
, 223382143
, 223705174
, 226460906
, 242590891
, 248390482
, 250184664
, 252110159
, 252224388
, 252451605
, 96100998
|
|||||
| ChEBI ID |
ChEBI:76010
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Dolutegravir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Tarascon Pocket Pharmacopoeia 2018 Classic Shirt-Pocket Edition. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.